| RS2128819989 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS2128820009 |
GCK
|
Health Risk |
Pathogenic |
— |
| RS2128820046 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS2128820597 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 2, Monogenic diabetes |
| RS2128820605 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2128820620 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS2128820681 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2128821468 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS2128821473 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2128821476 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS2128821490 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS2128821509 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS2128821512 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2128821515 |
GCK
|
Health Risk |
Pathogenic |
— |
| RS2128821570 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 3, Maturity-onset diabetes of the young |
| RS2128821587 |
GCK
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young type 2 |
| RS2128821589 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2128821624 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS2128821636 |
GCK
|
Health Risk |
Likely pathogenic |
— |
| RS2128822050 |
GCK
|
Health Risk |
Likely pathogenic |
— |
| RS2128822093 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2128822108 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS2128822614 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Permanent neonatal diabetes mellitus 1, Permanent neonatal diabetes mellitus 1 |
| RS2128822633 |
GCK
|
Health Risk |
Likely pathogenic |
— |
| RS2128822650 |
GCK
|
Health Risk |
Pathogenic |
— |
| RS2128822656 |
GCK
|
Health Risk |
Likely pathogenic |
— |
| RS2128822668 |
GCK
|
Health Risk |
Pathogenic |
— |
| RS2128822695 |
GCK
|
Health Risk |
Likely pathogenic |
Hyperinsulinism due to glucokinase deficiency, Hyperinsulinism due to glucokinase deficiency |
| RS2128822720 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2128823089 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS2128823091 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS2128823130 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS2128823146 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2128823213 |
GCK
|
Health Risk |
Pathogenic |
— |
| RS2128825710 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2128826930 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome |
| RS2128829368 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2128829880 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome 4, Lynch syndrome 4 |
| RS2128830113 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2128830784 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS2128830974 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 4 |
| RS2128834774 |
GCK
|
Health Risk |
Pathogenic |
— |
| RS2128835130 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2128835296 |
EYA1
|
Health Risk |
Likely pathogenic |
Branchiootic syndrome 1, Branchiootic syndrome 1 |
| RS2128835339 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2128835431 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2128836980 |
LPL
|
Health Risk |
Likely pathogenic |
— |
| RS2128837004 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2128837699 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2128838006 |
LPL
|
Health Risk |
Likely pathogenic |
— |
| RS2128838150 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2128838178 |
LPL
|
Health Risk |
Likely pathogenic |
— |
| RS2128838185 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperlipidemia, familial combined |
| RS2128838188 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipidemia, familial combined |
| RS2128838194 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS2128838491 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2128838546 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2128838564 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperlipidemia, familial combined |
| RS2128838568 |
LPL
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2128838569 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2128839190 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hyperlipoproteinemia |
| RS2128839227 |
LPL
|
Health Risk |
Likely pathogenic |
Hyperlipidemia, familial combined |
| RS2128839576 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2128839600 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS2128839623 |
LPL
|
Health Risk |
Likely pathogenic |
— |
| RS2128839625 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2128839831 |
LPL
|
Health Risk |
Likely pathogenic |
— |
| RS2128844640 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2128845440 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2128845860 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2128846824 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 4 |
| RS2128847171 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2128850253 |
EYA1
|
Health Risk |
Pathogenic |
Anhydramnios, Bilateral renal agenesis |
| RS2128850318 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Otofaciocervical syndrome 1 |
| RS2128850357 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2128850745 |
EYA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Branchiootorenal syndrome 1, Melnick-Fraser syndrome |
| RS2128850973 |
EYA1
|
Health Risk |
Pathogenic |
Branchiootic syndrome 1, Branchiootic syndrome 1 |
| RS2128851100 |
EYA1
|
Health Risk |
Likely pathogenic |
— |
| RS2128851194 |
EYA1
|
Health Risk |
Likely pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2128853368 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS2128853806 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2128853840 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2128854024 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2128854105 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2128854556 |
EYA1
|
Health Risk |
Likely pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2128854635 |
EYA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2128854678 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2128860927 |
NOBOX
|
Health Risk |
Pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS2128861344 |
NOBOX
|
Health Risk |
Pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS2128865599 |
ARFGEF1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2128865814 |
PMS2
|
Health Risk |
Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2128865982 |
PMS2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2128866045 |
PMS2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2128866103 |
PMS2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2128870578 |
ARFGEF1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2128886555 |
ATP6V1B2
|
Health Risk |
Pathogenic |
ATP6V1B2 related neurodevelopmental disorders, Zimmermann-Laband syndrome 2 |
| RS2128900324 |
ARFGEF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Focal-onset seizure |
| RS2128904607 |
EYA1
|
Health Risk |
Likely pathogenic |
— |
| RS2128904613 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2128904621 |
EYA1
|
Health Risk |
Likely pathogenic |
Branchiootorenal syndrome 1, Branchiootorenal syndrome 1 |